We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGP
4551
DELISTED
Teekay LNG Partners L.P.
TGP
$3K ﹤0.01%
277
+77
+39% +$864
JAX
4552
DELISTED
J. Alexander's Holdings, Inc.
JAX
$3K ﹤0.01%
482
-4,616
-91% -$20.2K
EXFO
4553
DELISTED
EXFO INC.
EXFO
$3K ﹤0.01%
978
-922
-49% -$3.37K
JIH
4554
DELISTED
Juniper Industrial Holdings, Inc.
JIH
$3K ﹤0.01%
314
-6,890
-96% -$69.9K
NBLX
4555
DELISTED
Noble Midstream Partners LP
NBLX
$3K ﹤0.01%
+500
New +$4.21K
RNET
4556
DELISTED
RigNet, Inc.
RNET
$3K ﹤0.01%
713
-2,972
-81% -$10.3K
SNDE
4557
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$3K ﹤0.01%
1,294
-1,235
-49% -$2.95K
SMMCU
4558
DELISTED
South Mountain Merger Corp. Unit
SMMCU
$3K ﹤0.01%
293
MLPI
4559
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$3K ﹤0.01%
+349
New +$3.72K
FHK
4560
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
$3K ﹤0.01%
79
-3
-4% -$97
GNCA
4561
DELISTED
Genocea Biosciences, Inc.
GNCA
$3K ﹤0.01%
+1,504
New +$3.95K
PFIN
4562
DELISTED
P&F Industries
PFIN
$3K ﹤0.01%
707
+609
+621% +$2.86K
THCAU
4563
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
$3K ﹤0.01%
319
LIVKU
4564
DELISTED
LIV Capital Acquisition Corp. Unit
LIVKU
$3K ﹤0.01%
277
ACNT icon
4565
Ascent Industries
ACNT
$138M
$2K ﹤0.01%
289
-2,643
-90% -$17.9K
AIFA
4566
All In FutureTech Alliance Inc
AIFA
$20.3M
$2K ﹤0.01%
233
-517
-69% -$5.59K
AMZA icon
4567
InfraCap MLP ETF
AMZA
$475M
$2K ﹤0.01%
180
AXR icon
4568
AMREP Corp
AXR
$115M
$2K ﹤0.01%
414
-433
-51% -$2.08K
BAK icon
4569
Braskem
BAK
$881M
$2K ﹤0.01%
312
-4,318
-93% -$37.1K
BOTJ icon
4570
Bank Of The James
BOTJ
$124M
$2K ﹤0.01%
+206
New +$1.9K
BSET icon
4571
Bassett Furniture
BSET
$170M
$2K ﹤0.01%
+119
New +$1.24K
CQQQ icon
4572
Invesco China Technology ETF
CQQQ
$3.24B
$2K ﹤0.01%
33
CREX icon
4573
Creative Realities
CREX
$39.3M
$2K ﹤0.01%
544
+296
+119% +$1.56K
CSPI icon
4574
CSP Inc
CSPI
$84.6M
$2K ﹤0.01%
386
+136
+54% +$576
DGP icon
4575
DB Gold Double Long ETN due February 15, 2038
DGP
$251M
$2K ﹤0.01%
46

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.